Independent Double Check / Require Witness

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

4 posts / 0 new
Log in or register to post comments
Last post
Wed, 05/01/2019 - 21:13
#1
Joel W Daniel
Joel W Daniel's picture
Offline
Last seen: 18 hours 5 min ago
Joined: 01/25/2018 - 09:33
Independent Double Check / Require Witness

We are undertaking an overhaul of the which medications/processes require an independent double check / witness within the EMR. It is widely publicized that IDCs are commonly overused and misused. This in-turn degrades the utility of IDCs put in the correct place on correct meds/processes.

The goal would be to develop guidelines that could be used to determine if a med/process qualifies for an IDC, then it would go to the Medication Safety Team to make final determination along with other recommendations.

I am most interested in what is done in other facilites/organizations:
1. Do you have an outlined process for IDCs?
2. How often are IDCs reviewed?
3. How is Nursing educated as to what is being asked to be double-checked at the individual location within the medication management cascade?
4. If your hospital/system does review, are there metrics that are associated with the review? If so, can I contact you to see how these are abstracted?

Thank you for any assistance.

Tags: 

Top